Search for: All records

ABSTRACT A three‐dimensional convolutional neural network (3D‐CNN) was developed for the analysis of volumetric optical coherence tomography (OCT) images to enhance endoscopic guidance during percutaneous nephrostomy. The model was performance‐benchmarked using a 10‐fold nested cross‐validation procedure and achieved an average test accuracy of 90.57% across a dataset of 10 porcine kidneys. This performance significantly exceeded that of 2D‐CNN models that attained average test accuracies ranging from 85.63% to 88.22% using 1, 10, or 100 radial sections extracted from the 3D OCT volumes. The 3D‐CNN (~12 million parameters) was benchmarked against three state‐of‐the‐art volumetric architectures: the 3D Vision Transformer (3D‐ViT, ~45 million parameters), 3D‐DenseNet121 (~12 million parameters), and the Multi‐plane and Multi‐slice Transformer (M3T, ~29 million parameters). While these models achieved comparable inferencing accuracy, the 3D‐CNN exhibited lower inference latency (33 ms) than 3D‐ViT (86 ms), 3D‐DenseNet121 (58 ms), and M3T (93 ms), representing a critical advantage for real‐time surgical guidance applications. These results demonstrate the 3D‐CNN's capability as a powerful and practical tool for computer‐aided diagnosis in OCT‐guided surgical interventions. 

The variability and biases in the real-world performance benchmarking of deep learning models for medical imaging compromise their trustworthiness for real-world deployment. The common approach of holding out a single fixed test set fails to quantify the variance in the estimation of test performance metrics. This study introduces NACHOS (Nested and Automated Cross-validation and Hyperparameter Optimization using Supercomputing) to reduce and quantify the variance of test performance metrics of deep learning models. NACHOS integrates Nested Cross-Validation (NCV) and Automated Hyperparameter Optimization (AHPO) within a parallelized high-performance computing (HPC) framework. NACHOS was demonstrated on a chest X-ray repository and an Optical Coherence Tomography (OCT) dataset under multiple data partitioning schemes. Beyond performance estimation, DACHOS (Deployment with Automated Cross-validation and Hyperparameter Optimization using Supercomputing) is introduced to leverage AHPO and cross-validation to build the final model on the full dataset, improving expected deployment performance. The findings underscore the importance of NCV in quantifying and reducing estimation variance, AHPO in optimizing hyperparameters consistently across test folds, and HPC in ensuring computational feasibility. By integrating these methodologies, NACHOS and DACHOS provide a scalable, reproducible, and trustworthy framework for DL model evaluation and deployment in medical imaging. 

Abstract Epidural anesthesia helps manage pain during different surgeries. Nonetheless, the precise placement of the epidural needle remains a challenge. In this study, we developed a probe based on polarization‐sensitive optical coherence tomography (PS‐OCT) to enhance the epidural anesthesia needle placement. The probe was tested on six porcine spinal samples. The multimodal imaging guidance used the OCT intensity mode and three distinct PS‐OCT modes: (1) phase retardation, (2) optic axis, and (3) degree of polarization uniformity (DOPU). Each mode enabled the classification of different epidural tissues through distinct imaging characteristics. To further streamline the tissue recognition procedure, convolutional neural network (CNN) were used to autonomously identify the tissue types within the probe's field of view. ResNet50 models were developed for all four imaging modes. DOPU imaging was found to provide the highest cross‐testing accuracy of 91.53%. These results showed the improved precision by PS‐OCT in guiding epidural anesthesia needle placement. 

Abstract Colorectal cancer (CRC) cells display remarkable adaptability, orchestrating metabolic changes that confer growth advantages, pro‐tumor microenvironment, and therapeutic resistance. One such metabolic change occurs in glutamine metabolism. Colorectal tumors with high glutaminase (GLS) expression exhibited reduced T cell infiltration and cytotoxicity, leading to poor clinical outcomes. However, depletion of GLS in CRC cells has minimal effect on tumor growth in immunocompromised mice. By contrast, remarkable inhibition of tumor growth is observed in immunocompetent mice when GLS is knocked down. It is found that GLS knockdown in CRC cells enhanced the cytotoxicity of tumor‐specific T cells. Furthermore, the single‐cell flux estimation analysis (scFEA) of glutamine metabolism revealed that glutamate‐to‐glutathione (Glu‐GSH) flux, downstream of GLS, rather than Glu‐to‐2‐oxoglutarate flux plays a key role in regulating the immune response of CRC cells in the tumor. Mechanistically, inhibition of the Glu‐GSH flux activated reactive oxygen species (ROS)‐related signaling pathways in tumor cells, thereby increasing the tumor immunogenicity by promoting the activity of the immunoproteasome. The combinatorial therapy of Glu‐GSH flux inhibitor and anti‐PD‐1 antibody exhibited a superior tumor growth inhibitory effect compared to either monotherapy. Taken together, the study provides the first evidence pointing to Glu‐GSH flux as a potential therapeutic target for CRC immunotherapy.